Zobrazeno 1 - 10
of 260
pro vyhledávání: '"T F, Orntoft"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Luo, Ziheng1,2 (AUTHOR), Cheng, Xiang1,2 (AUTHOR), Feng, Bin1,2 (AUTHOR), Fan, Duoyang1,2 (AUTHOR), Liu, Xiaohui1,2 (AUTHOR), Xie, Ruyan1,2 (AUTHOR), Luo, Ting1,2 (AUTHOR), Wegner, Seraphine V.3 (AUTHOR), Ma, Dayou2 (AUTHOR), Chen, Fei1,2 (AUTHOR) fechen@csu.edu.cn, Zeng, Wenbin1,2 (AUTHOR) wbzeng@csu.edu.cn
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-30. 30p.
Autor:
H, Ewald, F P, Wikman, B M, Teruel, H N, Buttenschön, M, Torralba, T D, Als, A, El Daoud, T J, Flint, T H, Jorgensen, L, Blanco, T A, Kruse, T F, Orntoft, O, Mors
Publikováno v:
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. (1)
Homozygosity mapping is a very powerful method for finding rare recessive disease genes in monogenic disorders and may also be useful for locating risk genes in complex disorders, late onset disorders where parents often are not available, and for ra
Publikováno v:
Cancer research. 61(16)
Members of the epidermal growth factor (EGF) family have been suggested as prognostic markers in patients with bladder cancer. Thus far, there has been no consensus on their usefulness. We report an analysis of six ligands and two receptors of which
Publikováno v:
Cancer research. 60(23)
Cell growth regulators include proteins of the p53 pathway encoded by the genes CDKN2A (p16, p14arf), MDM2, TP53, and CDKN1A (p21) as well as proteins encoded by genes like RB1, E2F, and MYCL. In the present study we investigated allelic deletions of
Publikováno v:
Clinical chemistry. 46(10)
Testing for mutations of the TP53 gene in tumors is a valuable predictor for disease outcome in certain cancers, but the time and cost of conventional sequencing limit its use. The present study compares traditional sequencing with the much faster mi
Autor:
J E, Celis, P, Celis, M, Ostergaard, B, Basse, J B, Lauridsen, G, Ratz, H H, Rasmussen, T F, Orntoft, B, Hein, H, Wolf, A, Celis
Publikováno v:
Cancer research. 59(12)
Here, we present a novel strategy for dissecting some of the steps involved in the squamous differentiation of the bladder urothelium leading to squamous cell carcinomas (SCCs). First, we used proteomic technologies and databases (http://biobase.dk/c
Autor:
J E, Celis, M, Ostergaard, H H, Rasmussen, P, Gromov, I, Gromova, H, Varmark, H, Palsdottir, N, Magnusson, I, Andersen, B, Basse, J B, Lauridsen, G, Ratz, H, Wolf, T F, Orntoft, P, Celis, A, Celis
Publikováno v:
Electrophoresis. 20(2)
In our laboratories we are exploring the possibility of using proteome expression profiles of fresh bladder tumors (transitional cell carcinomas, TCCs; squamous cell carcinomas, SCCs) and random biopsies as fingerprints to subclassify histopathologic
Publikováno v:
Electrophoresis. 20(2)
To search for bladder squamous cell carcinoma markers that are released to the urine a blind and systematic analysis of the protein profiles of fresh tumors, their secreted proteins, as well as the patient's urine was carried out using state-of-the-a
Publikováno v:
The Journal of urology. 161(4)
Twenty fresh surgical specimens of human bladder tumors were tested for their ability to adhere to recombinant P and E-selectin. The adhesion was correlated to immunological detection of carbohydrate structures.A static titertray assay with immobiliz